TrialThe Lancet. Oncology2018

Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial.

Mack Roach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.